LQDA
Drug Manufacturers - Specialty & Generic · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Liquidia Corp publishes a filing, an earnings call transcript or a press release.
Get LQDA alertsThe proxy statement of Liquidia Corp reports total compensation of $2,680,954 for Scott Moomaw in fiscal 2025, including a base salary of $449,904. Disclosed compensation is on record for 3 fiscal years. Scott Moomaw has spoken on 2 earnings calls across 1 company, most recently for Liquidia Corp on August 12, 2026. Liquidia Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Liquidia Corp includes Damian deGoa (CEO and Board Member), Joanna Horobin (CEO), Paul B. Manning (CEO and Board Member) and 7 others.
“So on the Salesforce expansion, I think the good news is we have a lot of opportunity both on the existing customer front as well as the expanding front, as you phrased it, Julian.”
“No, I would completely just agree with everything Roger said. It's been interesting to see PH get off to a fast start. But as we mentioned, PHILD has come on strong in, you know, about half.”
Proxy statement
Start not stated–present
Last confirmed April 24, 2026
LQDA
Drug Manufacturers - Specialty & Generic · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Liquidia Corp (LQDA) | Chief Commercial Officer | $449,904 | $2,680,954 |
| 2024 | Liquidia Corp (LQDA) | Chief Commercial Officer | $436,800 | $1,851,703 |
| 2023 | Liquidia Corp (LQDA) | Chief Commercial Officer | $420,000 | $1,712,842 |